story of the week
Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
J. Clin. Oncol 2018 Sep 21;[EPub Ahead of Print], C Cruz, A Llop-Guevara, JE Garber, BK Arun, JA Pérez Fidalgo, A Lluch, ML Telli, C Fernández, C Kahatt, CM Galmarini, A Soto-Matos, V Alfaro, A Pérez de la Haza, SM Domchek, S Antolin, L Vahdat, NM Tung, R Lopez, J Arribas, A Vivancos, J Baselga, V Serra, J Balmaña, SJ IsakoffFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.